Continuation or Revision of NIDCR Clinical Trial Implementation Cooperative Agreement (UH3 Clinical Trial Required)
ID: 336832Type: Posted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Eligible Applicants

Others

Funding Category

Health

Funding Instrument

Cooperative Agreement

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes
Timeline
    Description

    The National Institutes of Health (NIH) is inviting applications for the continuation or revision of ongoing clinical trials supported by the National Institute of Dental and Craniofacial Research (NIDCR) through the UH3 Cooperative Agreement mechanism. This funding opportunity aims to support clinical trials focused on diagnostic, prevention, or treatment methodologies for oral health issues, allowing for competing renewal applications to extend trials needing additional time or follow-up, as well as competitive revisions for justified modifications in trial scope. The initiative emphasizes high-impact clinical research with strict adherence to guidelines for study design, participant recruitment, and ethical practices, ensuring data integrity and safety monitoring throughout the trial execution. Interested applicants must submit their proposals by January 8, 2025, and can reach out to the NIH OER Webmaster at OERWebmaster03@od.nih.gov for further inquiries. More details can be found in the full announcement at http://grants.nih.gov/grants/guide/pa-files/PAR-22-068.html.

    Point(s) of Contact
    Files
    Title
    Posted
    The National Institutes of Health (NIH) is inviting applications for the continuation or revision of ongoing clinical trials supported by the National Institute of Dental and Craniofacial Research (NIDCR) through the UH3 Cooperative Agreement mechanism. This funding opportunity targets clinical trials proposing diagnostic, prevention, or treatment methodologies for oral health issues. Applicants can submit competing renewal applications to extend trials that require additional time for completion or follow-up on long-term outcomes. Competitive revisions may also be requested for justified modifications in trial scope. Key dates include submission deadlines between March 2024 and January 2025, with specific instructions on prior consultations with NIDCR staff encouraged. The maximum project period for funding is five years, with no specific cap on the budget, though detailed justifications are necessary for higher budget requests. Eligible applicants include various educational and governmental institutions, along with nonprofits and for-profit organizations, but must maintain required registrations. Overall, the initiative emphasizes high-impact clinical research and adherence to rigorous guidelines for study design, participant recruitment, and ethical practices. Maintaining data integrity and safety monitoring during trial execution is paramount.
    Similar Opportunities
    Continuation or Revision of NIDCR Clinical Trial Planning and Implementation Cooperative Agreement (UH3 Clinical Trial Required)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity for the continuation or revision of clinical trials under the National Institute of Dental and Craniofacial Research (NIDCR) through a UH3 Exploratory/Developmental Cooperative Agreement. This initiative aims to support competing renewals or competitive revisions of ongoing clinical trials that focus on dental, oral, and craniofacial health, emphasizing the importance of structured data generation in advancing healthcare research. Eligible applicants include a wide range of institutions, such as public and private entities, nonprofits, and government organizations, with the application deadline set for January 6, 2028. Interested parties can find more information and contact NIH Grants Information at grantsinfo@nih.gov for inquiries regarding the application process.
    NIDCR Clinical Trial Planning and Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a Funding Opportunity Announcement (FOA) for the NIDCR Clinical Trial Planning and Implementation Cooperative Agreement (UG3/UH3), aimed at supporting research applications focused on planning and executing clinical trials related to dental, oral, and craniofacial health. This funding opportunity is structured in two phases: an initial one-year planning phase (UG3) followed by a potential five-year implementation phase (UH3), contingent upon meeting specific scientific milestones and feasibility requirements. The initiative seeks to expedite the development of evidence-based approaches to improve health outcomes in dentistry, emphasizing rigorous adherence to ethical and regulatory standards throughout the trial process. Interested applicants, including various higher education institutions and nonprofit organizations, must submit their applications by January 8, 2025, and can find additional information at the NIH grants website or contact the NIH OER Webmaster at FBOWebmaster@OD.NIH.GOV for assistance.
    NIDCR Drug, Biologic, Device and/or Procedure Intervention Clinical Trial Planning and Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity through the NIDCR Drug, Biologic, Device, and Procedure Intervention Clinical Trial Planning and Implementation Cooperative Agreement, designated as UG3/UH3. This initiative aims to support the planning and execution of clinical trials that enhance dental, oral, and craniofacial health, utilizing a two-phased approach: a one-year UG3 planning phase followed by a potential five-year UH3 implementation phase. Eligible applicants include higher education institutions, nonprofits, and local or state governments, with a focus on proposals that test FDA-regulated products and involve significant NIH engagement. Interested parties should note that the application deadline is January 6, 2028, and can find further details and contact information at grantsinfo@nih.gov or through the provided link to the full opportunity announcement at https://grants.nih.gov/grants/guide/pa-files/PAR-25-057.html.
    NIDCR Behavioral and Social Intervention Clinical Trial Planning and Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is inviting applications for the NIDCR Behavioral and Social Intervention Clinical Trial Planning and Implementation Cooperative Agreement (UG3/UH3), aimed at supporting research in behavioral and social interventions related to dental, oral, and craniofacial health. This funding opportunity encourages the development of clinical trials through a phased approach, beginning with a planning phase (UG3) lasting up to two years, which may transition into a clinical trial implementation phase (UH3) of up to five years, contingent upon meeting specific scientific milestones. The program emphasizes rigorous intervention studies that engage various stakeholders and adhere to the NIH Stage Model of intervention development, with applications due by 5:00 PM local time on January 7, 2025. For further inquiries, applicants can contact the NIH OER Webmaster at OERWebmaster03@od.nih.gov, and additional details can be found at the provided link to the full announcement.
    NIDCR Small Research Grants for Oral Health Data Analysis and Statistical Methodology Development (R03 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced the "NIDCR Small Research Grants for Oral Health Data Analysis and Statistical Methodology Development" (R03 Clinical Trial Not Allowed), aimed at supporting innovative research projects that utilize existing dental, oral, or craniofacial databases for secondary statistical analyses or the development of new statistical methodologies. This funding opportunity is particularly focused on studies that do not involve clinical trials and emphasizes the importance of addressing causal relationships in dental and oral health, with a goal of advancing clinical practices and knowledge. Eligible applicants include a wide range of entities such as higher education institutions, non-profits, and government organizations, with funding available for direct costs up to $100,000 per year, totaling a maximum of $200,000 over two years. Interested parties must submit their applications electronically via Grants.gov by May 7, 2025, and can direct inquiries to the NIH OER Webmaster at OERWebmaster03@od.nih.gov.
    NIDCR Prospective Observational or Biomarker Validation Study Cooperative Agreement (U01 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity through the National Institute of Dental and Craniofacial Research (NIDCR) for investigator-initiated observational studies or biomarker validation studies that require prospective data collection. This cooperative agreement aims to support research that enhances oral health by generating robust clinical data and validating biomarkers with established preliminary data. The funding is available for projects up to five years, contingent upon NIH appropriations, and emphasizes the significance of the proposed research and the investigator's capability. Interested applicants can find more information and application guidelines at the provided link, with the application due date set for May 7, 2026, and inquiries directed to grantsinfo@nih.gov.
    NIDCR Small Grant Program for New Investigators (R03 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced the NIDCR Small Grant Program for New Investigators (R03), aimed at supporting early-stage scientists in the fields of oral, dental, and craniofacial research. This grant program is designed for New Investigators who have not previously received substantial independent R01 funding, enabling them to conduct pilot or feasibility studies that will generate preliminary data necessary for future competitive R01 applications. By fostering research in this critical area of public health, the program seeks to empower emerging researchers to address significant questions aligned with the NIDCR's mission. Eligible applicants can request funding of up to $100,000, with a submission deadline of January 25, 2025. For further information, applicants can contact the NIH OER Webmaster at FBOWebmaster@OD.NIH.GOV or visit the program's webpage at http://grants.nih.gov/grants/guide/pa-files/PAR-21-084.html.
    NIDCR Small Research Grants for Analyses of Existing Genomics Data (R03 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH), through the National Institute of Dental and Craniofacial Research (NIDCR), has announced a funding opportunity for Small Research Grants (R03) aimed at analyzing existing genomic data related to dental, oral, and craniofacial health. This initiative encourages projects that utilize publicly available genomic data and advanced methodologies, focusing on oral health disparities and biological pathways to identify intervention targets. The grant supports projects with budgets up to $200,000 over two years, with applications due by May 7, 2026. Interested applicants can find more information and guidelines at the NIH Grants website or contact NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    Organs-on-a-Chip in Dental, Oral, and Craniofacial Research (DOC-OoCs) (R01 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity titled "Organs-on-a-Chip in Dental, Oral, and Craniofacial Research (DOC-OoCs) (R01 Clinical Trial Not Allowed)" aimed at advancing the development of organ-on-a-chip (OoC) technologies for dental, oral, and craniofacial research. This initiative seeks to support interdisciplinary research that validates these microfluidic systems for disease modeling and pre-clinical efficacy studies, with the goal of establishing OoC technologies as viable alternatives to animal models. A total of $2 million is allocated for 4-5 grants, with individual project budgets capped at $500,000 annually and a project duration of up to five years. Applications are due by November 19, 2024, and interested parties can find more information and guidelines at the NIH grants website or contact NIH Grants Information at grantsinfo@nih.gov.
    NIDDK High Risk Multi-Center Clinical Study Cooperative Agreement (U01 Clinical Trial Required)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is inviting applications for the NIDDK High Risk Multi-Center Clinical Study Cooperative Agreement (U01), aimed at supporting investigator-initiated, high-risk clinical trials that involve multiple clinical centers. Applicants must propose hypothesis-driven studies that focus on diseases relevant to the mission of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), with an emphasis on enhancing diverse perspectives in research. This funding opportunity is crucial for advancing therapeutic studies that can significantly improve clinical practices and public health outcomes. Interested applicants should note that the application period opens on January 5, 2024, with a closing date of November 5, 2026, and are encouraged to consult with NIDDK staff prior to submission. For further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov.